Company Monitoring Page for Regeneron

latest headlines for company on cafepharma

Regeneron revenue rises 11.7 pct on Eylea eye drug
Yahoo/Reuters
Thu, 02/9/17 - 11:18 am
Tags:
Regeneron, earnings, Eylea
Sanofi, Regeneron win a crucial stay of execution on Praluent
Endpoints
Wed, 02/8/17 - 09:36 pm
Tags:
Sanofi, Regeneron, Praluent, Amgen, Repatha
Earnings Preview: What To Expect From Regeneron On Thursday
Forbes
Wed, 02/8/17 - 09:29 am
Tags:
Regeneron, earnings
When it comes to PCSK9s, payers resisted — and sales flopped
Medical Marketing and Media
Wed, 01/11/17 - 09:54 am
Tags:
PCSK9 inhibitors, payers, Amgen, Sanofi, Regeneron, Repatha, Praluent
Regeneron CEO says Amgen not putting patients first in patent dispute
Yahoo/Reuters
Tue, 01/10/17 - 09:19 am
Tags:
Regeneron, Pharma CEOs, Amgen, Sanofi, patents, Repatha, Praluent, Len Schleifer
2 Top Stocks in Biotech
Motley Fool
Mon, 01/9/17 - 09:47 am
Tags:
biotech, Portola Pharmaceuticals, Regeneron
Judge’s unusual ruling on Amgen, Regeneron patent case puts billions of dollars at stake
Marketwatch
Sun, 01/8/17 - 03:32 pm
Tags:
Amgen, Sanofi, Regeneron, Repatha, Praluent
Regeneron and Sanofi to Appeal U.S. District Court Rulings in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection
Yahoo
Fri, 01/6/17 - 10:22 am
Tags:
Regeneron, Sanofi, Amgen, patents, Repatha, Praluent
Amgen Wins Ban on Sanofi’s Praluent Cholesterol Drug Sales
Bloomberg
Fri, 01/6/17 - 09:51 am
Tags:
Amgen, Sanofi, Regeneron, Praluent, Repatha, patents
Sanofi, Regeneron one step closer to owing PCSK9 royalties as judge upholds Amgen patent ruling
Fierce Pharma
Thu, 01/5/17 - 09:20 am
Tags:
Sanofi, Regeneron, PCSK9 inhibitors, Amgen, Praluent, Repatha
Biotech Stocks: What to Watch in 2017
Motley Fool
Tue, 01/3/17 - 10:02 am
Tags:
biotech, M&A, drug launches, Gilead Sciences, Incyte, Spinraza, Biogen, Ionis Pharmaceuticals, Amgen, Regeneron, Sanofi
Regeneron Eyes A Comeback In 2017
Yahoo/Benzinga
Wed, 12/28/16 - 11:37 am
Tags:
Regeneron
Once-promising diabetes ‘breakthrough’ comes unglued with a major retraction
Stat
Wed, 12/28/16 - 11:09 am
Tags:
diabetes, stem cells, Regeneron
Biotechs line up to tap growing ophthalmics market
BioPharma Dive
Thu, 12/22/16 - 10:25 am
Tags:
Ophthalmic Drugs Market, Ocular Therapeutix, Eylea, Restasis, Lucentis, Regeneron, Roche, Allergan
Amgen, Regeneron May Yet Get Rich From Their Cholesterol Drugs
Seeking Alpha
Tue, 12/20/16 - 12:04 pm
Tags:
Amgen, Regeneron, Praluent, Repatha, Sanofi
Reeling Ophthotech eviscerates staff, laying off up to 135; Booming Regeneron adds more space
Endpoints
Fri, 12/16/16 - 09:50 am
Tags:
Ophthotech, layoffs, Fovista, Regeneron
What Fovista's Fail Means For OHR Pharma
Yahoo/Benzinga
Wed, 12/14/16 - 09:17 am
Tags:
Fovista, Ohr Pharmaceutical, Ophthotech, Regeneron, rinucumab, squalamine, wet age-related macular degeneration
Pharma execs assess landscape under President Trump
Drug Delivery Business
Sat, 12/3/16 - 09:22 am
Tags:
Donald Trump, pharma industry, drug pricing, Regeneron, Allergan
Regeneron, Sanofi Drug Delayed by Plant Snag
Investopedia
Thu, 12/1/16 - 04:33 pm
Tags:
Regeneron, Sanofi, Dupixent, drug manufacturing, Sarilumab
No early success for Regeneron, Sanofi in PhIII outcomes study for PCSK9 drug Praluent
Endpoints
Thu, 11/17/16 - 09:54 am
Tags:
Regeneron, Sanofi, Praluent, PCSK9 inhibitors

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.